Metz, Martin http://orcid.org/0000-0002-4070-9976
Vadasz, Zahava http://orcid.org/0000-0003-2899-5508
Kocatürk, Emek http://orcid.org/0000-0003-2801-0959
Giménez-Arnau, Ana M. http://orcid.org/0000-0001-5434-7753
Article History
First Online: 16 May 2020
Compliance with Ethical Standards
:
: Martin Metz has received honoraria as speakers and/or consultant from Aralez, Argenx, Bayer, Celgene, Moxie, Novartis, Roche, Sanofi, and Uriach. Zahava Vadasz has received honoraria as speaker from Novartis, RAFA, and Sanofi; and has received research grants supported from Novartis. Emek Kocatürk has received honoraria as speaker and consultant for Bayer, Novartis, and Sanofi. Ana M Giménez-Arnau has served as medical advisor for Uriach Pharma, Genentech, Novartis, FAES, GlaxoSmithKline (GSK), and Sanofi; has received research grants from Uriach Pharma, Novartis, and Instituto Carlos III—La Federación Española de Enfermedades Raras (FEDER); and is involved in educational activities for Uriach Pharma, Novartis, Genentech, Menarini, LEO Pharma, GSK, Merck Sharp & Dohme, Almirall, and Sanofi.
: This article does not contain any studies with human participants or animals performed by any of the authors.